Download video

Clinical manifestation and complications of Herpes Zoster in HIV

132 views

MBBS NAIJA

6 months ago

Clinical manifestation and complications of Herpes Zoster in HIV

Clinical manifestation and complications of Herpes Zoster in HIV

CACLP 2025 onsite - The Convergence of Laboratory Medicine and In Vitro Diagnostics
2:19
CACLP 2025 onsite - The Convergence of Laboratory Medicine and In Vitro Diagnostics
by CACLP
A review of the clinical safety and efficacy of ruxolitinib 10 years after its approval for PV
2:17
A review of the clinical safety and efficacy of ruxolitinib 10 years after its approval for PV
by VJHemOnc – Video Journal of Hematology \& HemOnc
BRCA2 \& Chemoresistance: Breakthrough Discovery Explained | Cancer Research Update
4:25
BRCA2 \& Chemoresistance: Breakthrough Discovery Explained | Cancer Research Update
by Timeless Moments
What everybody should know about Clinical Trials! - Part 5 - Phase 2 Trials
1:44
What everybody should know about Clinical Trials! - Part 5 - Phase 2 Trials
by GCP-Mindset - All About Clinical Research
Case #2: Treating a Patient with Stage IV NSCLC with EGFR - 2025 Case Based Panel Discussions
31:07
Case #2: Treating a Patient with Stage IV NSCLC with EGFR - 2025 Case Based Panel Discussions
by Global Resource for Advancing Cancer Education
What Is It Like Being A Clinical Trial Project Manager and Director For Pharmaceutical Sponsors?
53:09
What Is It Like Being A Clinical Trial Project Manager and Director For Pharmaceutical Sponsors?
by Dan Sfera
hepatocellular carcinoma
45:53
hepatocellular carcinoma
by Stanley Kim
The IMproveMF study: combining imetelstat with ruxolitinib for the treatment of myelofibrosis
0:58
The IMproveMF study: combining imetelstat with ruxolitinib for the treatment of myelofibrosis
by VJHemOnc – Video Journal of Hematology \& HemOnc
HER2+ Metastatic Breast Cancer Grand Rounds: Latest Advances
1:17:53
HER2+ Metastatic Breast Cancer Grand Rounds: Latest Advances
by MedAll
Adherence Matters: The Key to Optimizing Clinical Outcomes 20\/3\/25, 1pm CEST (Final Announcement)
0:54
Adherence Matters: The Key to Optimizing Clinical Outcomes 20\/3\/25, 1pm CEST (Final Announcement)
by P2PMD
Final results of a Phase II study of add-on parsaclisib for pts with MF and suboptimal rux response
1:07
Final results of a Phase II study of add-on parsaclisib for pts with MF and suboptimal rux response
by VJHemOnc – Video Journal of Hematology \& HemOnc
Phase I\/II tral of NKT2152, an HIF-2α inhibitor, in pre-treated accRCC
1:48
Phase I\/II tral of NKT2152, an HIF-2α inhibitor, in pre-treated accRCC
by VJOncology
Update From AACR-NCI-EORTC: PYNNACLE phase 2 study
6:27
Update From AACR-NCI-EORTC: PYNNACLE phase 2 study
by COR2ED The Heart of Medical Education
The expanding role of immunotherapy in HCC
4:30
The expanding role of immunotherapy in HCC
by COR2ED The Heart of Medical Education
Two-year results from the COMMODORE 2 trial of crovalimab in complement inhibitor-naïve PNH
1:07
Two-year results from the COMMODORE 2 trial of crovalimab in complement inhibitor-naïve PNH
by VJHemOnc – Video Journal of Hematology \& HemOnc
Recent advances in precision oncology and future implications
4:12
Recent advances in precision oncology and future implications
by COR2ED The Heart of Medical Education
The CLL2-BZAG trial: MRD-guided zanubrutinib, venetoclax, and obinutuzumab in R\/R CLL
1:11
The CLL2-BZAG trial: MRD-guided zanubrutinib, venetoclax, and obinutuzumab in R\/R CLL
by VJHemOnc – Video Journal of Hematology \& HemOnc
The Road to a Successful Inspection - What’s Being Inspected and Why It Matters - Part 2
17:26
The Road to a Successful Inspection - What’s Being Inspected and Why It Matters - Part 2
by GCP-Mindset - All About Clinical Research
Introduction to Clinical Pharmacology and Therapeutics - Part 2: Pharmacokinetic Concepts
54:09
Introduction to Clinical Pharmacology and Therapeutics - Part 2: Pharmacokinetic Concepts
by NIH Clinical Center
LEAP-012 study: Expert insights on multimodal treatment for intermediate HCC
5:13
LEAP-012 study: Expert insights on multimodal treatment for intermediate HCC
by COR2ED The Heart of Medical Education